References
- NygrenPLarssonROverview of the clinical efficacy of investigational anticancer drugsJ Intern Med20032531467512588538
- KerwinSMSoy saponins and the anticancer effects of soybeans and soy-based foodsCurr Med Chem Anticancer Agents20044326327215134504
- RaoAVSungMKSaponins as anticarcinogensJ Nutr19951253 Suppl717S724S7884557
- TianFZhangXTongYPE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro andin vivoCancer Biol Ther20054887488216082187
- TinMMChoCHChanKJamesAEKoJKAstragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograftCarcinogenesis20072861347135517148504
- HwangSJChaJYParkSGDiol- and triol-type ginseng saponins potentiate the apoptosis of NIH3T3 cells exposed to methyl methanesulfonateToxicol Appl Pharmacol2002181319220212079428
- WangZPSaponins as Anticancer Agent United States Patent 20050175623 A12005
- KensilCRPatelULennickMMarcianiDSeparation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortexJ Immunol199114624314371987271
- KerstenGFSpiekstraABeuveryECCrommelinDJOn the structure of immune-stimulating saponin-lipid complexes (iscoms)Biochim Biophys Acta1991106221651712004105
- RonnbergBFekaduMMoreinBAdjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrixVaccine19951314137513828585296
- MoreinBHuKLovgrenKD’HondtESinghMANew ISCOMs meet unsettled vaccine demandsVaccine Adjuvants and Delivery SystemsHoboken, NJJohn Wiley & Sons, Inc2007191222
- LovgrenKMoreinBTheISCOMan antigen delivery system with built-in adjuvantMol Immunol19912832852862017197
- LovgrenKMoreinBThe ISCOM™ Technology. Vaccin adjuvants: Preparation methods and research protocolsMethods Mol Med200042239258
- MoreinBSundquistBHoglundSDalsgaardKOsterhausAISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature198430859584574606709052
- DaltonWDurieBAlbertsDGerlachJCressACharacterization of a new drug-resistant human myeloma cell line that expresses p-glycoproteinCancer Res198646512551302875788
- BellamyWDaltonWGleasonMGroganTTrentJDevelopment and characterization of a melphalan-resistant human multiple myeloma cell lineCancer Res19915199510021988143
- BotlingJLimingaGLarssonRNygrenPNilssonKDevelopment of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170 kDa p-glycoproteinInt J Cancer1994582692747913083
- DanksMSchmidtCCirtainMSuttleDBeckWAltered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry198827886188692853972
- LarssonRKristensenJSandbergCNygrenPLaboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia using a fluorometric microculture cytotoxicity assay (FMCA)Int J Cancer1992501771851730510
- LovborgHNygrenPLarssonRMultiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828Mol Cancer Ther20043552152615141009
- HilfRGoldenbergHMichelIOrlandoRAArcherFLEnzymes, nucleic acids, and lipids in human breast cancer and normal breast tissueCancer Res1970306187418824318708
- PerkinsRGKummerowFAMajor lipid classes in plasma membrane isolated from liver of rats fed a hepatocarcinogenBiochim Biophys Acta197642434694801259971
- DumitriuIEBaruahPManfrediAABianchiMERovere-QueriniPHMGB1: guiding immunity from withinTrends Immunol200526738138715978523
- WikmanMFriedmanMPinitkiatisakulSGeneral strategies for efficient adjuvant incorporation of recombinant subunit immunogensVaccine200523171823312335
- HuKFLovgren-BengtssonKMoreinBImmunostimulating complexes (ISCOMs) for nasal vaccinationAdv Drug Deliv Rev2001511314915911516775